Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Hydroxyprophylmethylcellulose manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : Egypt

Clear all

4 products found

hydroxyprophylmethylcellulose

Ophthalmic solution 3 mg/ml - 15 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
Egypt
GMP approvals
WHO
Comments
Will be available in Q4-2024
Manufacturer #274
This pharmaceutical company, established over three decades ago, boasts a strong presence across numerous regions, including the Middle East and Africa. The company's portfolio encompasses a wide range of products, including prescription and over-the-counter medications, as well as food supplements. Their manufacturing facilities adhere to stringent quality standards, boasting EU and US GMP certifications. The company is known for its dedication to research and development, reflected in its numerous product patents. Their key therapeutic areas include infectious diseases, cardiovascular health, and anti-viral therapies. This commitment to innovation has resulted in a significant impact on patient care, particularly in the field of hepatitis C treatment.

Manufacturer usually replies in 1 days

hydroxyprophylmethylcellulose

Eye drops 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #20785

Manufacturer usually replies in nan days

dextran 70 + hydroxyprophylmethylcellulose

Eye drops 1mg + 3mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #16472
This pharmaceutical company, based in the Middle East, has been operating for over four decades. With a focus on production, they are a leading manufacturer in the region, particularly known for their antibiotics, lyophilized products, and spansule capsules. They hold significant market share in the local market and boast the number one spot in pharmaceutical product exports. They offer a wide range of prescription drugs, including those in solid, injectable, oral, and liquid forms. The company has obtained EU and US GMP approvals, indicating adherence to high manufacturing standards. Their production lines encompass various therapeutic areas, with key focuses on antibiotics, oncology, and cardiology. While no specific product patents were mentioned, their commitment to research and development suggests an ongoing effort to innovate and expand their offerings.

Manufacturer usually replies in 6 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible